Literature DB >> 28464787

Directed Differentiation and Paracrine Mechanisms of Mesenchymal Stem Cells: Potential Implications for Tendon Repair and Regeneration.

Bingyu Zhang1, Qing Luo1, Alexander Halim1, Yang Ju2, Yasuyuki Morita2, Guanbin Song1.   

Abstract

BACKGROUND: Tendon is composed of connective tissue, is able to retract with high tensile force, and plays a significant role in musculoskeletal motion. However, inappropriate physical training or accidents often result in tendon injuries. So far, the functional healing of injured tendon is still a great challenge in orthopedics. Mesenchymal stem cells (MSCs) are multilineage cells with the ability to self-renew and differentiate into a variety of cell types, including tenocytes. The plasticity of MSCs gives rise to the chance of improved healing of injured tendons and even tissue-engineered tendons. Recently, more and more works have shown that the paracrine mechanisms of MSCs also play a critical role in driving the tendon repair process.
OBJECTIVE: The purpose of this review is to summarize the current knowledge of the induction of tenogenic differentiation of MSCs by mechanical, chemical and mechanochemical stimulations. The role of paracrine mechanisms of MSCs during the repair of injured tendons is also discussed.
CONCLUSION: The multilineage potential and the paracrine effects of MSCs create the chance for improved healing of injured tendons and even tissue-engineered tendons. The understanding of the regulation of the two different repair mechanisms (directed differentiation and paracrine) of MSCs has important implications for tendon repair and regeneration. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Mesenchymal stem cells; directed differentiation; injury; paracrine; repair; tendon

Mesh:

Year:  2017        PMID: 28464787     DOI: 10.2174/1574888X12666170502102423

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  7 in total

1.  Regeneration of a full-thickness defect in rotator cuff tendon with umbilical cord-derived mesenchymal stem cells in a rat model.

Authors:  Ji-Hye Yea; InJa Kim; Gayoung Sym; Jin-Kyung Park; Ah-Young Lee; Byeong Chan Cho; Tae Soo Bae; Byoung Jae Kim; Chris Hyunchul Jo
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

2.  Failed Surgery for Patellar Tendinopathy in Athletes: Midterm Results of Further Surgical Management.

Authors:  Nicola Maffulli; Francesco Oliva; Gayle D Maffulli; Filippo Migliorini
Journal:  Orthop J Sports Med       Date:  2021-03-30

3.  The Cincinnati incision is safe and effective for revision surgery for insertional tendinopathy of the Achilles tendon.

Authors:  Nicola Maffulli; Nikolaos Gougoulias; Gayle D Maffulli; Francesco Oliva; Filippo Migliorini
Journal:  Sci Rep       Date:  2022-04-22       Impact factor: 4.996

4.  Adipose-Derived Mesenchymal Stem Cell-Derived Extracellular Vesicles Rescue Tendon Injury in Rat via the miR-19 a/IGFBP3 Axis.

Authors:  Haibo Zhao; Hongyuan Jiang; Haoyun Zhang; Zewen Sun; Qian Lin; Tianrui Wang; Tengbo Yu; Yingze Zhang
Journal:  Stem Cells Int       Date:  2022-09-12       Impact factor: 5.131

5.  Enhanced Effect of Tendon Stem/Progenitor Cells Combined With Tendon-Derived Decellularized Extracellular Matrix on Tendon Regeneration.

Authors:  Haixin Song; Zi Yin; Tao Wu; Yangzheng Li; Xun Luo; Mingzhu Xu; Lihong Duan; Jianhua Li
Journal:  Cell Transplant       Date:  2018-10-09       Impact factor: 4.064

6.  Regeneration of a full-thickness defect of rotator cuff tendon with freshly thawed umbilical cord-derived mesenchymal stem cells in a rat model.

Authors:  Ji-Hye Yea; Jin-Kyung Park; In Ja Kim; Gayoung Sym; Tae-Soo Bae; Chris Hyunchul Jo
Journal:  Stem Cell Res Ther       Date:  2020-09-07       Impact factor: 6.832

Review 7.  Umbilical Cord Mesenchymal Stem Cell Therapy for Regenerative Treatment of Rheumatoid Arthritis: Opportunities and Challenges.

Authors:  Xiaolan Lv; Liming Wang; XiaoRong Zou; Shigao Huang
Journal:  Drug Des Devel Ther       Date:  2021-09-15       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.